Risk Stratification Value of Biomarkers in Patients With Myocarditis
ConditionMyocarditis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age3-80
SponsorFirst Affiliated Hospital Xi'an Jiaotong University
About this trial
The aim of this study is to collect clinical data and biological specimens from patients with myocarditis and construct a predictive model for the prognosis of myocarditis.
Eligibility criteria
Qualifiers
All patients should meet the diagnostic criteria for myocarditis
Patients who are regularly followed up at the corresponding cardiovascular center
Disqualifiers
Age <3 years or >80 years
Pregnant or lactating women
The patient refused to sign the informed consent and refused to participate in the study
None of the above is consistent, but the patient cannot sign the informed consent temporarily due to coma and other reasons, and there is no legal representative to sign it instead. Depending on the condition, the patient may not wake up to sign the informed consent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,000 Participants
are grouped into 1 trial groupLocations
1First Affiliated Hospital of Xi'an Jiaotong University710061, Xi'anShaanxi, China
Sponsors and collaborators
First Affiliated Hospital Xi'an Jiaotong University
Lead sponsor
Source ClinicalTrials.gov